Archives: Agenda

• Identifying protocol design elements that unintentionally increase patient burden in oncology trials
• Simplifying eligibility criteria without compromising scientific rigor
• Incorporating patient feedback into trial design to improve participation experience
• Considering recruitment and retention aspects

• Enhancing biomarker selection to speed up oncology trial timelines
• Road mapping how to identify effective biomarkers to enhance oncology clinical trials
• Understanding regulatory considerations surrounding biomarker qualification

With a disproportionately large number of patients willing to participate in global studies, Canada’s world-class researchers and diverse patient population, trial cost efficiency, robust health authority with reliable process times, consistent data quality, and national therapeutic expertise in oncology make it an attractive country for enrollment to your global clinical trial program.

This presentation explores how to succeed with your oncology trial in Canada with insights on:

• The Perception Gap
• How Sponsors Receive: Predictability. Speed. Quality. Partner Accountability
• Competitive Structural Advantages
• Real-World Global Trial Examples
• What to Expect in a Partner for the Region

• Tackling challenges in cell therapy study design to reduce timelines and ensure quality and relevance for the field
• Partnering effectively with CROs: what constitutes a productive collaboration in the cell therapy space
• Logistics in cell therapy: challenges and solutions

How strategic collaboration can accelerate innovation:

• Moving from transactional execution to consultative partnership
• How CROs can become strategic problem solvers, not just service providers
• Building trust transparency and shared accountability